ProcuraAxisBeta
Sign inCreate Free Account
Home / Opportunities / Opportunity
PROCUREMENT OPPORTUNITY

Supply of Plasmids and Synthetic DNA for Viral Vector Manufacture

NHS Blood and Transplant · Preliminary market engagement notice on Find a Tender

Tender information last checkedLast checked 30 Sept 2026, 07:23.

Opportunity overview

As part of a preliminary market engagement exercise, NHS Blood & Transplant (NHSBT) are seeking to engage with suppliers of nucleic acids including plasmid DNA; synthetically produced DNA and/or enzymatically produced DNA. The intended use of the nucleic acids by NHSBT includes: a) the GMP grade production of gene therapy vectors such as lentiviral, adeno-associated viral vectors and novel gene therapy vectors, for clinical trials and commercial production where applicable; b) gene therapy vectors suitable for pre-clinical studies, such as toxicology and biodistribution studies and gene therapy vectors suitable for R&D purposes.

Classification

  • CPV33698000 — Clinical products

Lots

  • Lot 1Value not stated

Documents and notices

Published notice details

Additional information from the published procurement release. Fields appear only when supplied by the source; check the original notice and tender documents before acting.

Scope, procedure and submissions

Id
C382225
Status
planning
Above Threshold
Yes
Main Procurement Category
goods

Legal basis

Id
2023/54
Scheme
UKPGA

Techniques

Has Framework Agreement
Yes

Communication

Future Notice Date
8 Dec 2025, 23:59

Lots and requirements

Entry 1
Id
1
Status
planning

Contract period

Ends
14 Jun 2034, 23:59
Starts
15 Jun 2026, 00:00

Items and delivery

Item 1
Id
1
Related Lot
1

Delivery locations

Entry 1
Region
UKK11
Country
GB
Country Name
United Kingdom

Additional Classifications

Entry 1
Id
33698000
Scheme
CPV
Description
Clinical products

Planning and budget

Documents

Entry 1
Id
048226-2025
Format
text/html
Notice Type
UK2
Description
Preliminary market engagement notice on Find a Tender
Document Type
marketEngagementNotice
Published
13 Aug 2025, 08:21

Milestones

Entry 1
Id
engagement
Type
engagement
Status
scheduled
Due
12 Sept 2025, 23:59
Description
NHSBT conducted initial market engagement for ' Supply of Viral Vector Plasmids', via issue of a PIN under the Procurement Contract Regulations (Notice Identifier: 2024/S 000-029545). NHSBT have since updated the requirement to include synthetically produced DNA and/or enzymatically produced DNA. Therefore NHSBT are looking to engage further with suppliers who may have been missed from the initial market engagement, due to synthetic plasmids not being included. If you are interested in taking part in the market engagement, please contact james.marshall2@nhsbt.nhs.uk by no later than 12:00 hrs (GMT) on 12/09/2025. Market engagement is likely to take place via video calls in September 2025. There is no guarantee that a formal procurement process will be launched as a result of this early market engagement exercise, nor that any contract(s) will be placed. No remuneration or compensation etc will be paid to organisations who take part in this early market engagement exercise. Suppliers should take part in this process only on the basis that they fully understand and accept this position.

Buyer, suppliers and contacts

Organisation 1
Id
GB-PPON-PDBY-6395-VWBP
Name
NHS Blood and Transplant

Roles

buyer

Address

Region
UKK12
Country
GB
Locality
Bristol
Postal Code
BS34 7QH
Country Name
United Kingdom
Street Address
500 North Bristol Park

Details

Classifications

Entry 1
Id
publicAuthorityCentralGovernment
Scheme
UK_CA_TYPE
Description
Public authority - central government

Identifier

Id
PDBY-6395-VWBP
Scheme
GB-PPON

Contact

Recorded locations

  • Buyer location · Bristol · UKK12 · BS34 7QH · United Kingdom
  • Delivery location · UKK11 · United Kingdom

Notice and amendment history

1 published notice version reviewed by ProcuraAxis.

1 VERSION
  1. ocds-h6vhtk-0586a2-2025-08-13T08:21:27+01:00Preliminary market engagement notice on Find a Tender ·